FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: REAUTHORIZATION OF THE PRESCRIPTION DRUG USER FEE ACT; PUBLIC MEETING; REQUEST FOR COMMENTS

WASHINGTON, May 19 -- Food and Drug Administration has issued a notice called: Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments.

The notice was published in the Federal Register on May 19 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. PDUFA authorizes FDA to collect user fees to support the process for the review of human drug applications. The current legislative authority for PDUFA expires in September 2027. At ...